Skip to main content

Advertisement

Log in

Association Between Genetic Variations of Vascular Endothelial Growth Factor Receptor 2 and Glioma in the Chinese Han Population

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Tumor angiogenesis, which is an important step in the development of cancer, is directly regulated by vascular endothelial growth factor receptor 2 (VEGFR-2). In this study, we examined the association of five potentially functional VEGFR-2 polymorphisms with glioma risk in a Chinese Han population. Three SNPs, rs2071559, rs7667298 and rs2305948, showed a statistically significant increased association with the risk of glioma (P = 0.006, 0.005, and 0.012, respectively). Both haplotype and diplotype analyses consistently revealed that subjects carrying two copies of the haplotype “CGT” had a 42% reduced glioma risk compared with their respective noncarriers. Our findings suggested that VEGFR-2 gene variants might contribute to glioma susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Albuquerque RJ, Hayashi T, Cho WG, Kleinman ME, Dridi S, Takeda A et al (2009) Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 15:1023–1030

    Article  PubMed  CAS  Google Scholar 

  • Becker J, Pavlakovic H, Ludewig F, Wilting F, Weich HA, Albuquerque R et al (2010) Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. Clin Cancer Res 16:1431–1441

    Article  PubMed  CAS  Google Scholar 

  • Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, Bruner JM et al (2001) Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst 93:1553–1557

    Article  PubMed  CAS  Google Scholar 

  • Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il’yasova D et al (2008) Brain tumor epidemiology consortium. Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer 113:1953–1968

    Article  PubMed  Google Scholar 

  • Clauss M (2000) Molecular biology of the VEGF and the VEGF receptor family. Semin Thromb Hemost 26:561–569

    Article  PubMed  CAS  Google Scholar 

  • DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114–123

    Article  PubMed  CAS  Google Scholar 

  • Derynck R, Akhurst RJ, Balmain A (2001) TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29:117–129

    Article  PubMed  CAS  Google Scholar 

  • Ebos JM, Bocci G, Man S, Thorpe PE, Hicklin DJ, Zhou D et al (2004) A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma. Mol Cancer Res 2:315–326

    PubMed  CAS  Google Scholar 

  • Ebos JM, Lee CR, Bogdanovic E, Alami J, Van Slyke P, Francia G et al (2008) Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Cancer Res 68:521–529

    Article  PubMed  CAS  Google Scholar 

  • Försti A, Jin Q, Altieri A, Johansson R, Wagner K, Enquist K et al (2007) Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis. Breast Cancer Res Treat 101:83–93

    Article  PubMed  Google Scholar 

  • Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229

    Article  PubMed  CAS  Google Scholar 

  • Giatromanolaki A, Koukourakis MI, Sivridis E, Chlouverakis G, Vourvouhaki E, Turley H et al (2007) Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer. Eur J Clin Invest 37:878–886

    Article  PubMed  CAS  Google Scholar 

  • Guo S, Colbert LS, Fuller M, Zhang Y, Gonzalez-Perez RR (2010) Vascular endothelial growth factor receptor-2 in breast cancer. Biochim Biophys Acta 1806:108–121

    PubMed  CAS  Google Scholar 

  • Huang H, Held-Feindt J, Buhl R, Mehdorn HM, Mentlein R (2005) Expression of VEGF and its receptors in different brain tumors. Neurol Res 4:371–377

    Article  Google Scholar 

  • Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R et al (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11:3647–3653

    Article  PubMed  CAS  Google Scholar 

  • Jurinke C, van den Boom D, Cantor CR, Koster H (2002) Automated genotyping using the DNA MassArray technology. Methods Mol Biol 187:179–192

    PubMed  CAS  Google Scholar 

  • Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N et al (2004) Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 56:953–959

    Article  PubMed  CAS  Google Scholar 

  • Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH, Park JY et al (2008) Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 14:62–66

    Article  PubMed  CAS  Google Scholar 

  • Leppänen VM, Prota AE, Jeltsch M, Anisimov A, Kalkkinen N, Strandin T et al (2010) Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proc Natl Acad Sci U S A 107:2425–2430

    Article  PubMed  Google Scholar 

  • Lewontin RC (1988) On measures of gametic disequilibrium. Genetics 120:849–852

    PubMed  CAS  Google Scholar 

  • Li R, Zhao Y, Fan W, Chen H, Chen Y, Liu Y et al (2011) Possible association between polymorphisms of human vascular endothelial growth factor a gene and susceptibility to glioma in a Chinese population. Int J Cancer 128:166–1675

    Article  PubMed  CAS  Google Scholar 

  • Little MP, de Vathaire F, Shamsaldin A, Oberlin O, Campbell S, Grimaud E et al (1998) Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer 78:269–275

    Article  PubMed  CAS  Google Scholar 

  • Liu Y, Zhang H, Zhou K, Chen L, Xu Z, Zhong Y et al (2007) Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis 28:1906–1913

    Article  PubMed  CAS  Google Scholar 

  • Liu Y, Zhou K, Zhang H, Shugart YY, Chen L, Xu Z et al (2008) Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat 29:381–389

    Article  PubMed  Google Scholar 

  • Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93–108

    Article  PubMed  Google Scholar 

  • Park HW, Lee JE, Shin ES, Lee JY, Bahn JW, Oh HB et al (2006) Association between genetic variations of vascular endothelial growth factor receptor 2 and atopy in the Korean population. J Allergy Clin Immunol 117:774–779

    Google Scholar 

  • Puputti M, Tynninen O, Sihto H, Blom T, Mäenpää H, Isola J et al (2006) Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas. Mol Cancer Res 4:927–934

    Article  PubMed  CAS  Google Scholar 

  • Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M (1996) Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7:213–221

    PubMed  CAS  Google Scholar 

  • Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M (1995) A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10:135–147

    PubMed  CAS  Google Scholar 

  • Silva SR, Bowen KA, Rychahou PG, Jackson LN, Weiss HL, Lee EY et al (2011) VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis. Int J Cancer 128:1045–1056

    Article  PubMed  CAS  Google Scholar 

  • Sjöström S, Wibom C, Andersson U, Brännström T, Broholm H, Johansen C et al (2011) Genetic variations in VEGF and VEGFR2 and glioblastoma outcome. J Neurooncol 104:523–527

    Article  PubMed  Google Scholar 

  • Spannuth WA, Nick AM, Jennings NB, Armaiz-Pena GN, Mangala LS, Danes CG et al (2009) Functional significance of VEGFR-2 on ovarian cancer cells. Int J Cancer 124:1045–1053

    Article  PubMed  CAS  Google Scholar 

  • Stephens M, Donnelly P (2003) A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169

    Article  PubMed  CAS  Google Scholar 

  • Tanno S, Ohsaki Y, Nakanishi K, Toyoshima E, Kikuchi K (2004) Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer 46:11–19

    Article  PubMed  Google Scholar 

  • Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y et al (2007) Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 50:760–767

    Article  PubMed  CAS  Google Scholar 

  • Zhang W, Sun K, Zhen Y, Wang D, Wang Y, Chen J et al (2009) VEGF receptor-2 variants are associated with susceptibility to stroke and recurrence. Stroke 40:2720–2726

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Haishi Zhang and Fengping Huang for subject enrollment. They also thank all staff members of the Department of Neurosurgery of Huashan Hospital for their cooperation during data collection. This work was partially supported by the Natural Science Foundation of China (81001114), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, and the Doctoral Fund of Ministry of Education of China.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yao Zhao or Ying Mao.

Additional information

Hongyan Chen and Weimen Wang contributed equally to this work.

Yao Zhao and Ying Mao jointly directed the work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, H., Wang, W., Xingjie, Z. et al. Association Between Genetic Variations of Vascular Endothelial Growth Factor Receptor 2 and Glioma in the Chinese Han Population. J Mol Neurosci 47, 448–457 (2012). https://doi.org/10.1007/s12031-012-9705-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-012-9705-9

Keywords

Navigation